Pediatric Vaccines Market Size, Trends, Analysis, and Outlook By Vaccine (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Others), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), Others), by Region, Country, Segment, and Companies, 2024-2030
The global Pediatric Vaccines market size is poised to register 9.79% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Pediatric Vaccines market across By Vaccine (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Others), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), Others).
The Pediatric Vaccines market is experiencing robust growth driven by the increasing emphasis on childhood immunization programs, rising awareness about the importance of vaccination in preventing infectious diseases, and the growing demand for novel pediatric vaccine formulations offering improved safety, efficacy, and coverage against a wide range of pathogens. Pediatric vaccines play a crucial role in protecting infants, children, and adolescents from vaccine-preventable diseases such as measles, mumps, rubella, polio, diphtheria, pertussis, tetanus, influenza, pneumococcal infections, and human papillomavirus (HPV) infections. Key factors driving market expansion include the expanding pediatric vaccine pipeline, driven by advances in vaccine technology, recombinant DNA technology, and adjuvant formulations, enabling the development of next-generation vaccines targeting emerging infectious diseases and vaccine-resistant pathogens. Additionally, the increasing focus on universal immunization coverage, national vaccination campaigns, and routine vaccination schedules recommended by public health authorities and professional medical associations is driving vaccine uptake and market penetration in pediatric populations. Moreover, the growing investments in pediatric vaccine research and development, vaccine manufacturing capacity expansion, and global immunization initiatives, such as the Expanded Program on Immunization (EPI) by the World Health Organization (WHO), are driving innovation and market growth in the pediatric vaccines segment. Furthermore, the rising demand for combination vaccines, needle-free delivery systems, and temperature-stable vaccine formulations suitable for use in resource-limited settings is expanding market opportunities for vaccine manufacturers and healthcare providers worldwide. With the continuous focus on vaccine safety, efficacy, and accessibility, the Pediatric Vaccines market is poised for further expansion in the coming years.
Pediatric Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Pediatric Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Pediatric Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Pediatric Vaccines industry.
Key market trends defining the global Pediatric Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Pediatric Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Pediatric Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Pediatric Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Pediatric Vaccines industry
Leading Pediatric Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Pediatric Vaccines companies.
Pediatric Vaccines Market Study- Strategic Analysis Review
The Pediatric Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Pediatric Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Pediatric Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Pediatric Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Pediatric Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Pediatric Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Pediatric Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Pediatric Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Pediatric Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Pediatric Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Pediatric Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Pediatric Vaccines in Asia Pacific. In particular, China, India, and South East Asian Pediatric Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Pediatric Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Pediatric Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Pediatric Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Pediatric Vaccines.
Pediatric Vaccines Market Company Profiles
The global Pediatric Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca plc, GlaxoSmithKline PLC, Indian Immunologicals Ltd, Merck & Co. Inc, Mitsubishi Tanabe Pharma Corp, Novavax Inc, Pfizer Inc, Sanofi SA, Seqirus, Sinovac Biotech Ltd
Recent Pediatric Vaccines Market Developments
The global Pediatric Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Pediatric Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others
Geographical Segmentation:
AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd
Formats Available: Excel, PDF, and PPT
The Pediatric Vaccines market is experiencing robust growth driven by the increasing emphasis on childhood immunization programs, rising awareness about the importance of vaccination in preventing infectious diseases, and the growing demand for novel pediatric vaccine formulations offering improved safety, efficacy, and coverage against a wide range of pathogens. Pediatric vaccines play a crucial role in protecting infants, children, and adolescents from vaccine-preventable diseases such as measles, mumps, rubella, polio, diphtheria, pertussis, tetanus, influenza, pneumococcal infections, and human papillomavirus (HPV) infections. Key factors driving market expansion include the expanding pediatric vaccine pipeline, driven by advances in vaccine technology, recombinant DNA technology, and adjuvant formulations, enabling the development of next-generation vaccines targeting emerging infectious diseases and vaccine-resistant pathogens. Additionally, the increasing focus on universal immunization coverage, national vaccination campaigns, and routine vaccination schedules recommended by public health authorities and professional medical associations is driving vaccine uptake and market penetration in pediatric populations. Moreover, the growing investments in pediatric vaccine research and development, vaccine manufacturing capacity expansion, and global immunization initiatives, such as the Expanded Program on Immunization (EPI) by the World Health Organization (WHO), are driving innovation and market growth in the pediatric vaccines segment. Furthermore, the rising demand for combination vaccines, needle-free delivery systems, and temperature-stable vaccine formulations suitable for use in resource-limited settings is expanding market opportunities for vaccine manufacturers and healthcare providers worldwide. With the continuous focus on vaccine safety, efficacy, and accessibility, the Pediatric Vaccines market is poised for further expansion in the coming years.
Pediatric Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Pediatric Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Pediatric Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Pediatric Vaccines industry.
Key market trends defining the global Pediatric Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Pediatric Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Pediatric Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Pediatric Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Pediatric Vaccines industry
Leading Pediatric Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Pediatric Vaccines companies.
Pediatric Vaccines Market Study- Strategic Analysis Review
The Pediatric Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Pediatric Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Pediatric Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Pediatric Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Pediatric Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Pediatric Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Pediatric Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Pediatric Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Pediatric Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Pediatric Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Pediatric Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Pediatric Vaccines in Asia Pacific. In particular, China, India, and South East Asian Pediatric Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Pediatric Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Pediatric Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Pediatric Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Pediatric Vaccines.
Pediatric Vaccines Market Company Profiles
The global Pediatric Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca plc, GlaxoSmithKline PLC, Indian Immunologicals Ltd, Merck & Co. Inc, Mitsubishi Tanabe Pharma Corp, Novavax Inc, Pfizer Inc, Sanofi SA, Seqirus, Sinovac Biotech Ltd
Recent Pediatric Vaccines Market Developments
The global Pediatric Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Pediatric Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Pediatric Vaccines Market Overview and Key Findings, 2024
1.2 Pediatric Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Pediatric Vaccines Market Growth Opportunities to 2030
1.4 Key Pediatric Vaccines Market Trends and Challenges
1.4.1 Pediatric Vaccines Market Drivers and Trends
1.4.2 Pediatric Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Pediatric Vaccines Companies
2. PEDIATRIC VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Pediatric Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Pediatric Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PEDIATRIC VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PEDIATRIC VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Pediatric Vaccines Market, 2025
5.2 Asia Pacific Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Pediatric Vaccines Market, 2025
5.5 Europe Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Pediatric Vaccines Market, 2025
5.8 North America Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Pediatric Vaccines Market, 2025
5.11 South America Pacific Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Pediatric Vaccines Market, 2025
5.14 Middle East Africa Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Pediatric Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Pediatric Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Pediatric Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Pediatric Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Pediatric Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Pediatric Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Pediatric Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Pediatric Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Pediatric Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Pediatric Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Pediatric Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Pediatric Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Pediatric Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Pediatric Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Pediatric Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Pediatric Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Pediatric Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Pediatric Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Pediatric Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Pediatric Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Pediatric Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Pediatric Vaccines Industry Drivers and Opportunities
7. PEDIATRIC VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PEDIATRIC VACCINES COMPANY PROFILES
8.1 Profiles of Leading Pediatric Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Pediatric Vaccines Market Overview and Key Findings, 2024
1.2 Pediatric Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Pediatric Vaccines Market Growth Opportunities to 2030
1.4 Key Pediatric Vaccines Market Trends and Challenges
1.4.1 Pediatric Vaccines Market Drivers and Trends
1.4.2 Pediatric Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Pediatric Vaccines Companies
2. PEDIATRIC VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Pediatric Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Pediatric Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PEDIATRIC VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PEDIATRIC VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Pediatric Vaccines Market, 2025
5.2 Asia Pacific Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Pediatric Vaccines Market, 2025
5.5 Europe Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Pediatric Vaccines Market, 2025
5.8 North America Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Pediatric Vaccines Market, 2025
5.11 South America Pacific Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Pediatric Vaccines Market, 2025
5.14 Middle East Africa Pediatric Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Pediatric Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Pediatric Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Pediatric Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Pediatric Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Pediatric Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Pediatric Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Pediatric Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Pediatric Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Pediatric Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Pediatric Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Pediatric Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Pediatric Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Pediatric Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Pediatric Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Pediatric Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Pediatric Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Pediatric Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Pediatric Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Pediatric Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Pediatric Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Pediatric Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Pediatric Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Pediatric Vaccines Industry Drivers and Opportunities
7. PEDIATRIC VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PEDIATRIC VACCINES COMPANY PROFILES
8.1 Profiles of Leading Pediatric Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
